[{"arm_notes": "", "treatment_id": null, "treatment_name": "IV Cohort : A single IV dose of Casirivimab(Genetical Recombination)1200mg and Imdevimab(Genetical Recombination)1200mg; a single IV dose of Casirivimab(Genetical Recombination)4000mg and Imdevimab(Genetical Recombination)4000mg or a single IV dose of placebe SC Cohort : A single SC dose of Casirivimab(Genetical Recombination)600mg and Imdevimab(Genetical Recombination)600mg or a single SC dose of placebo", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "IV", "treatment_id": 1864, "treatment_name": "Casirivimab+imdevimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "SC", "treatment_id": 1864, "treatment_name": "Casirivimab+imdevimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]